Last update Aug. 18, 2021
The root and leaves are used.
Contains mucilage, allantoin, phenolic acids (rosmarinic acid) and pyrrolizidine alkaloids (Fitoterapia.net).
Properties attributed without clear evidence of efficacy: topical anti-inflammatory.
Indications from Commission E of the German Ministry of Health (Blumenthal 1998) and the European Medicines Agency (EMA 2015 and 2009): bruises on intact skin.
Topical cutaneous administration on intact skin.
At the date of the last update, the authors did not find any published data on its excretion in breast milk.
The small dose and poor plasma absorption of most topical dermatological preparations make it unlikely that a significant amount will pass into breast milk.
Avoid putting on wounds or oral ingestion. Do not apply to the breasts or to areas of the mother’s skin with which the infant may come into contact.
Due to the content of pyrrolizidine alkaloids, which are hepatotoxic, carcinogenic and mutagenic, this plant is included in several lists of unauthorized products (EMA 2015, ONU 2005, MSC 2004, FDA 2001).
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM